Identifying New Memory and Brain Markers for Early Alzheimer's Disease
Principal Investigator
Mentors
-
David Berron, PhD
Project Goals
This project aims to identify new cognitive and neuroimaging markers associated with early stages of Alzheimer's disease, which can identify different disease stages and subtypes.
Project Summary
Despite newly available treatments for Alzheimer’s disease, dementia subtype specificity is important to determine prior to treatment to ensure safe and efficacious outcomes. Optimized cognitive assessments and imaging biomarkers are also essential for early detection and to monitor disease progression.
This project will address these challenges by developing new cognitive and neural markers sensitive to the early effects of Alzheimer’s. These markers can be used to screen for subtle memory changes, classify by subtype, and identify signatures of healthy brain function that can clarify mechanisms of disease-modifying effects on memory in early-phase clinical trials.
Publications
First published on: July 30, 2024
Last modified on: October 11, 2024